Evidence map›Paper›PMID 42691689›Full record

ReviewAutonomic neuroscience : basic & clinical2026

Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction.

Kamal Shouman, Michael Camilleri, Wolfgang Singer

Abstract readReview
In one paragraph

Review in Autonomic neuroscience : basic & clinical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kamal ShoumanDepartment of Neurology, Mayo Clinic, Rochester, MN, United States of America.
Michael CamilleriClinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Wolfgang SingerDepartment of Neurology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: singer.wolfgang@mayo.edu.

Funding

Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic ApproachR01NS092625 · NINDS · MAYO CLINIC ROCHESTER · PI SINGER, WOLFGANG, VEMURI, PRASHANTHI · 2015 to 2025
$6.6M
Parkinson Disease Neural Circuitry and Gastrointestinal PathobiologyR01DK135440 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL L. CAMILLERI · 2023 to 2026
$2.4M
Biomarkers for parkinsonian disorders in CNS-originating extracellular vesiclesR01NS126406 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GAL BITAN · 2026 to 2026
$769k
Save Kidneys in Cisplatin Chemotherapy by blocking HDAC6R56DK135540 · NIDDK · RHODE ISLAND HOSPITAL · PI DONG, ZHENG, ZHUANG, SHOUGANG · 2023 to 2023
$100k
FDA HHS R01 FD007290NIDDK NIH HHS R01 DK135440NIDDK NIH HHS R56 DK135540NINDS NIH HHS R01 NS092625NINDS NIH HHS R01 NS126406
6 · The paper itself

Abstract

Gastrointestinal (GI) symptoms are frequent in disorders that involve the autonomic nervous system (ANS) or the enteric neuromuscular apparatus. Although dysfunction may occur anywhere along the alimentary tract, gastric manifestations are often the most clinically visible 'end-organ' expression of autonomic disease because they drive nausea, vomiting, early satiety, postprandial distress, malnutrition risk, and impaired drug absorption. In this invited review, we summarize the organization of the GI neuromuscular apparatus, emphasizing how intrinsic (enteric) circuitry and extrinsic sympathetic and parasympathetic pathways cooperate to regulate gastrointestinal functions. We then link common symptom clusters (dysphagia, gastroparesis, intestinal pseudo-obstruction, constipation, diarrhea, and fecal incontinence) to likely neuroanatomic levels and review autonomic test batteries and motility studies that help characterize dysfunction. Finally, we discuss neurologic and systemic diseases in which autonomic and enteric involvement produce prominent gastric and broader GI phenotypes. These include cerebrovascular and cortical neurodegenerative disorders, Parkinson's disease, structural and inflammatory brainstem syndromes, primary autonomic failure and hereditary dysautonomia, postural orthostatic tachycardia syndrome, spinal cord disorders (including multiple sclerosis), peripheral neuropathies such as diabetes mellitus and amyloidosis, paraneoplastic and autoimmune autonomic neuropathies, and selected neuromuscular and myopathic conditions.

Indexed as

AutonomicConstipationDiarrheaDysphagiaEnteric nervous systemGastroparesisIncontinenceNeurologic disordersNeuropathyParasympatheticSympatheticVomiting

Identifiers

PMID42691689
PMCPMC13618994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.